UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

Heart Device Fails to Improve Longevity in New Amyloidosis Research

A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis.

For patients with transthyretin cardiac amyloidosis (TTR-CA), the implantable cardioverter-defibrillator (ICD) may not be delivering on its promise of providing life-saving health outcomes. Long considered a cornerstone treatment to prevent sudden cardiac death, experts now speculate the overall survival benefit conveyed by the pricey technology may no longer be significant in patients with impaired heart function.